CZ126699A3 - Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity - Google Patents

Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity Download PDF

Info

Publication number
CZ126699A3
CZ126699A3 CZ991266A CZ126699A CZ126699A3 CZ 126699 A3 CZ126699 A3 CZ 126699A3 CZ 991266 A CZ991266 A CZ 991266A CZ 126699 A CZ126699 A CZ 126699A CZ 126699 A3 CZ126699 A3 CZ 126699A3
Authority
CZ
Czechia
Prior art keywords
seq
tuberculosis
ala
pro
dna
Prior art date
Application number
CZ991266A
Other languages
Czech (cs)
English (en)
Inventor
Steven G. Reed
Yasir A. W. Skeiky
Davin C. Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas S. Vedvick
Daniel R. Twardzik
Michael J. Lodes
Original Assignee
Corixa Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by Corixa Corporation filed Critical Corixa Corporation
Publication of CZ126699A3 publication Critical patent/CZ126699A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CZ991266A 1996-10-11 1997-10-07 Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity CZ126699A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis

Publications (1)

Publication Number Publication Date
CZ126699A3 true CZ126699A3 (cs) 1999-09-15

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ991266A CZ126699A3 (cs) 1996-10-11 1997-10-07 Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity

Country Status (11)

Country Link
EP (1) EP0934415A2 (fr)
JP (1) JP2001500383A (fr)
AU (1) AU4750597A (fr)
BR (1) BR9712298A (fr)
CA (1) CA2268036A1 (fr)
CZ (1) CZ126699A3 (fr)
IL (2) IL129389A0 (fr)
NO (1) NO991693L (fr)
PL (1) PL333304A1 (fr)
TR (1) TR199901569T2 (fr)
WO (1) WO1998016645A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
CA2296419A1 (fr) * 1997-07-16 1999-01-28 Institut Pasteur Polynucleotide codant fonctionellement pour la proteine lhp de mycobacterium tuberculosis, fragments derives biologiquement actifs, et procedes utilisant ce polynucleotide
EP1484405A1 (fr) * 1997-11-10 2004-12-08 Statens Serum Institut Fragments d'acide nucléique et fragments polypeptidiques derivés de M. tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
EP1214088B1 (fr) 1999-05-04 2009-04-22 The University of Medicine and Dentistry of New Jersey Proteines exprimees par mycobacterium tuberculosis et non par bcg et employees en tant que vaccins et reactifs de diagnostic
ATE354663T1 (de) * 1999-10-07 2007-03-15 Corixa Corp Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
SI1542732T1 (sl) 2000-06-20 2010-01-29 Corixa Corp Csc The United Sta Fuzijski proteini Mycobacterium tuberculosis
WO2002004018A2 (fr) * 2000-07-10 2002-01-17 Colorado State University Research Foundation Vaccin de mi-vie et procédé pour renforcer l'immunité anti-mycobactérienne
JP2005504523A (ja) 2001-06-22 2005-02-17 ヘルス プロテクション エージェンシー 低酸素圧下で発現するマイコバクテリア抗原
US7393540B2 (en) 2001-07-04 2008-07-01 Health Protection Agency Mycobacterial antigens expressed during latency
CN100351374C (zh) * 2001-07-25 2007-11-28 东曹株式会社 用于检测结核分枝杆菌的寡核苷酸和方法
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
SG159555A1 (en) 2004-11-16 2010-03-30 Crucell Holland Bv Multivalent vaccines comprising recombinant viral vectors
ATE543832T1 (de) 2005-04-29 2012-02-15 Glaxosmithkline Biolog Sa Verfahren zur vorbeugung oder behandlung einer m.-tuberculosis-infektion
US7993657B2 (en) * 2005-07-26 2011-08-09 University Of Medicine And Dentistry Of New Jersey Antibody profiles characteristic of tuberculosis state
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
EP2368568A1 (fr) * 2006-11-01 2011-09-28 Immport Therapeutics, INC. Compositions et procédés pour antigènes immunodominants
KR20120129927A (ko) 2010-01-27 2012-11-28 글락소 그룹 리미티드 변형된 투베르쿨로시스 항원
CN115746092B (zh) * 2022-08-12 2024-08-13 齐鲁工业大学 具有抗氧化、抗衰老活性的钝顶螺旋藻藻蓝蛋白活性肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (fr) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Polypeptides et peptides recombinantes, acides nucléiques lesencodantes, et l'utilisation de celles-ci pour le diagnostique de la tuberculose
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
DE69637879D1 (de) * 1995-09-01 2009-04-30 Corixa Corp Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
WO1997009429A2 (fr) * 1995-09-01 1997-03-13 Corixa Corporation Composes et methodes de diagnostic de la tuberculose

Also Published As

Publication number Publication date
TR199901569T2 (xx) 2000-12-21
PL333304A1 (en) 1999-11-22
JP2001500383A (ja) 2001-01-16
NO991693L (no) 1999-06-09
WO1998016645A3 (fr) 1998-08-06
CA2268036A1 (fr) 1998-04-23
AU4750597A (en) 1998-05-11
IL129389A0 (en) 2000-02-17
EP0934415A2 (fr) 1999-08-11
NO991693D0 (no) 1999-04-09
IL121936A0 (en) 1998-03-10
WO1998016645A2 (fr) 1998-04-23
BR9712298A (pt) 2000-10-24

Similar Documents

Publication Publication Date Title
US6458366B1 (en) Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
CZ126699A3 (cs) Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity
WO1998016646A9 (fr) Composes et methodes utilises pour l'immunotherapie et le diagnostic de la tuberculose
WO1998016646A2 (fr) Composes et methodes utilises pour l'immunotherapie et le diagnostic de la tuberculose
US6350456B1 (en) Compositions and methods for the prevention and treatment of M. tuberculosis infection
SA99200488B1 (ar) تركيبات وطرق لاج والوقاية من الاصابة بعدوي بكتيريا العصيات الفطرية للدرنM.tuberculosis
AU727602B2 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6338852B1 (en) Compounds and methods for diagnosis of tuberculosis
EP0850305A2 (fr) Composes et methodes de diagnostic de la tuberculose
US6555653B2 (en) Compounds for diagnosis of tuberculosis and methods for their use
MXPA01009383A (es) Antigenos de tuberculosis y metodos para utilizar los mismos.
MXPA99003393A (en) Compounds and methods for diagnosis of tuberculosis
CN1241212A (zh) 免疫治疗和诊断结核病的化合物和方法
MXPA99003392A (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
CN1242047A (zh) 诊断结核病的化合物和方法
AU765833B2 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
KR20000049100A (ko) 결핵을 진단하는 화합물 및 방법

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic